Vanguard Group Inc Day One Biopharmaceuticals, Inc. Call Options Transaction History
Vanguard Group Inc
- $4.96 Trillion
- Q1 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding DAWN
# of Institutions
148Shares Held
60MCall Options Held
47.7KPut Options Held
61.3K-
Atlas Venture Life Science Advisors, LLC6.43MShares$86.8 Million13.29% of portfolio
-
Black Rock Inc. New York, NY5.03MShares$67.9 Million0.0% of portfolio
-
Franklin Resources Inc San Mateo, CA3.81MShares$51.4 Million0.02% of portfolio
-
State Street Corp Boston, MA2.89MShares$39.1 Million0.0% of portfolio
-
Viking Global Investors LP2.56MShares$34.5 Million0.16% of portfolio
About Day One Biopharmaceuticals, Inc.
- Ticker DAWN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 73,461,104
- Market Cap $992M
- Description
- Day One Biopharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops and commercializes targeted therapies for patients with genetically defined cancers. Its lead product candidate is DAY101, an oral brain-penetrant type II pan-rapidly accelerated fibrosarcoma kinase inhibitor that is in Phase II clinical trial for pediatric pa...